Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:

Recent Articles in Cell & Gene Therapy

Immunochina and EdiGene Team Up to Discover Allogeneic T-Cell Therapies
Nanjing Legend Approved for $100 Million US IPO on NASDAQ
Denovo to Acquire Gene Therapy Technology for Oncology from Tocagen
Gracell's IND for Allogenic CAR-T Accepted for Review in China
Nanjing Legend Raises $150 Million for Cell Therapies in an A Round/Pre-IPO Financing
Upcoming event
August 25-27, 2020
China Standard Time
ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China